NCT07017959View on ClinicalTrials.gov

Impact of a Human Origin Heat Inactivated Probiotic-Lactobacillus Paracasei D3.5 (LpD3.5) as Dietary Supplement on Gut Mucin and Intestinal Permeability in Adults With IBD

NANot yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 15, 2025

Primary Completion Date

December 15, 2025

Study Completion Date

December 30, 2025

Conditions
Inflammatory Bowel Diseases
Interventions
DIETARY_SUPPLEMENT

LpD3.5 supplementation.

Dietary Supplement: LpD3.5 are in the form of capsule where LpD3.5 contains 167 mg of LpD3.5, with the remaining portion consisting of inactive ingredients like maltodextrin

DIETARY_SUPPLEMENT

Placebo

Placebo capsules contain only inactive ingredient maltodextrin

Trial Locations (1)

33612

University of South Florida, Tampa

All Listed Sponsors
lead

University of South Florida

OTHER

NCT07017959 - Impact of a Human Origin Heat Inactivated Probiotic-Lactobacillus Paracasei D3.5 (LpD3.5) as Dietary Supplement on Gut Mucin and Intestinal Permeability in Adults With IBD | Biotech Hunter | Biotech Hunter